Current status of therapeutic plasma exchange in Korea

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 2, 2004, Pages 97-101

  Song, Eun Young ^a   Kwon, Seog Woon ^b   Kim, Dal Sik ^c   Kim, Dae Won ^d   Kim, Dong Wook ^e   Kim, Hyun Ok ^f   Park, Chong Won ^e   Suh, Jang Soo ^g   Ryang, Dong Wook ^h   Lee, Jeong Nyeo ⁱ   Lee, Jong Wook ^e   Lim, Young Ae ^j   Lim, Chae Seung ^k   Jeon, Dong Seok ^l   Han, Chi Wha ^e   Han, Tae Hee ⁱ   Han, Kyou Sup ^a  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Chon Buk Natl University Hospital

^d Samsung Medical Center   (South Korea)

^e The Catholic University of Korea College of Medicine   (South Korea)

^f Yonsei University   (South Korea)

^g Kyungpook National University Hospital   (South Korea)

^h Chonnam National University Medical School   (South Korea)

ⁱ Inje University College of Medicine   (South Korea)

^j Ajou University Medical CentSuwon   (South Korea)

^k Korea University Ansan Hospital   (South Korea)

^l Keimyung University   (South Korea)

more..

Author keywords

Korea; Plasma exchange; Registry; Therapeutic apheresis

Indexed keywords

BLOOD FILTRATION; CENTRIFUGATION; HEALTH SURVEY; HEMOLYTIC UREMIC SYNDROME; HOSPITAL; HUMAN; HYPOCALCEMIA; KOREA; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; TREATMENT OUTCOME;

HEALTH CARE SURVEYS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KOREA; MYASTHENIA GRAVIS; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REGISTRIES;

EID: 2942746240     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2003.00111.x     Document Type: Review

References (16)

1. McLeod BC, Price TH, Drew MJ. Apheresis: Principles and Practice, 1st edn. Bethesda, MD: AABB Press, 1997.
2. Kaplan AA. A Practical Guide to Therapeutic Plasma Exchange, 1st edn. Malden, MA: Blackwell Science, 1999.
3. Rock GA, Herbert CA. Therapeutic apheresis in Canada. The Canadian Apheresis Study Group. J Clin Apheresis 1992;7:47-8.
4. Rock G, Herbert C. The Canadian Apheresis Group and therapeutic plasma exchange. Transfus Sci 1999;20:145-50.
5. Korach JM, Bussel A, Gajdos P. The national survey of plasma exchange and therapeutic cytapheresis in France. Transf Sci 1995;16:363-70.
6. Korach JM, Petitpas D, Poiron L, Vincent N, Berger PH, Chillet P. 14 years of therapeutic plasma exchange in France. Transfus Apheresis Sci 2001;25:73-7.
7. Malchesky PS, Skibinski CI, Williams GW, Nosé Y. The International Apheresis Registry: Results of 1983 second pilot. Artif Organs 1987;11:173-82.
8. Malchesky PS, Koo AP, Rybicki LA. Apheresis technologies and clinical applications: the 2000 International Apheresis Registry. Ther Apher 2001;5:193-206.
9. Yeh JH, Chiu HC. Therapeutic apheresis in Taiwan. Ther Apher 2001;5:513-16.
10. Kwon OH, Park Q, Kim HO, Lee SJ, Han JS, Ko YW. Therapeutic plasma exchange in thrombotic thrombocytopenic purpura. Korean J Blood Transfus 1993;4:43-8.
11. Song KS, Yoon HS, Lee KW, Kim HS, Lee SY. The plasma exchange (9 cases). Korean J Laboratory Med 2000;58:437-45.
12. Um TH, Lee NY, Park H, Han KS, Kim SI. Experience of Therapeutic plasma exchanges in Seoul national University Hospital. Korean J Blood Transfus 1993;4:199-205.
13. Couriel D, Weinstein R. Complications of therapeutic plasma exchange: a recent assessment. J Clin Aphereris 1994;9:1-5.
14. Norda R, Stegmayr BG. Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis Study Group. Transfusion Apher Sci 2001;24:49-55.
15. Pritchard J. Novel therapeutic approaches to Guillain-Barré syndrome. Expert Opin Invest Drugs 2000;9:2307-18.
16. Korach JM, Berger P, Giraud C, Le Perff-Desman C, Chillet P. Role of replacement fluids in the immediate complications of plasma exchange. French Registry Cooperative Group. Intensive Care Med 1998;24:452-8.